|

Continuous Glucose Monitoring in Dialysis Patients to Overcome Dysglycemia Trial

RECRUITINGN/ASponsored by University of California, Irvine
Actively Recruiting
PhaseN/A
SponsorUniversity of California, Irvine
Started2023-12-12
Est. completion2026-01-31
Eligibility
Age18 Years – 99 Years
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →

NCT05509881

Summary

This randomized controlled trial will investigate whether use of continuous glucose monitoring (CGM) vs. usual care with self-monitored blood glucose 1) enhances glycemic control, 2) reduces hypoglycemia risk, and 3) improves quality of life, diabetes distress, and fear of hypoglycemia in hemodialysis patients with diabetes mellitus.

Eligibility

Age: 18 Years – 99 YearsHealthy volunteers accepted
Inclusion Criteria:

* Ability to provide written informed consent
* Age ≥18 years old
* End-stage kidney disease status receiving in-center hemodialysis ≥4 weeks
* Type 1 or type 2 diabetes
* Actively performing self-monitored blood glucose (SMBG) testing for ≥4 weeks
* ≥70% compliance wearing continuous glucose monitoring (CGM) device during the pre-trial period

Exclusion Criteria:

* Inability to provide informed consent or comply with the study protocol
* Limited visual acuity
* Inability to wear CGM device
* Prior use of CGM
* Active pregnancy or planning a pregnancy

Conditions4

Continuous Glucose MonitoringDiabete MellitusDiabetesHemodialysis

Locations1 site

University of California, Irvine
Orange, California, 92868
Connie Rhee312-420-8474crhee@uci.edu

Browse More Trials

Diabetes trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.